380
Participants
Start Date
May 31, 2013
Primary Completion Date
May 31, 2014
Study Completion Date
September 30, 2014
Dupilumab
Placebo
Birmingham
Mobile
Tucson
Bakersfield
San Diego
Santa Monica
Jacksonville
Ormond Beach
Skokie
New Orleans
Andover
Boston
Troy
St Louis
New York
Rochester
Winston-Salem
Portland
Pittsburgh
Johnston
Greer
Nashville
Houston
San Antonio
Seattle
Vancouver (2 Locations)
Winnipeg
Barrie
Hamilton
Markham
Oakville
Peterborough
Richmond Hill
Waterloo
Windsor
Saint-Hyacinthe
Québec
Kutná Hora
Náchod
Prague
Svitavy
Ústí nad Labem
Augsburg
Baden
Berlin
Bonn
Dresden
Dülmen
Frankfurt am Main
Frankfurt/Main, Hessen
Gera
Hamburg
Heidelberg
Kiel
Mahlow
Munich
Münster
Osnabrück
Tübingen
Borsod-Abauj-Zemplen
Budapest
Kaposvár
Szeged
Szolnok
Tolna
Fukuoka
Hokkaido
Saitama
Tokyo, Bunkyo-ku
Tokyo, Chiyoda-ku
Tokyo, Nakano-ku
Tokyo, Nerima-ku
Tokyo, Shibuya-ku
Tokyo, Shinagawa-ku
Tokyo, Shinjuku-ku (2 Locations)
Tokyo, Suginami-ku (2 Locations)
Yokohama
Gdansk (2 Locations)
Katowice
Lodz
Lublin
Poznan
Warsaw (2 Locations)
Wroclaw
Collaborators (1)
Sanofi
INDUSTRY
Regeneron Pharmaceuticals
INDUSTRY